Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 3fludarabine 2aldesleukin 2Sunitinib 2Fluorouracil 2Cyclophosphamide 2Bevacizumab 2trastuzumab deruxtecan 1sodium propionate 1semaglutide 1repotrectinib 1patritumab deruxtecan 1isosorbide-5-mononitrate 1fludarabine phosphate 1dehydroftorafur 1Tomography, X-Ray Computed 1Radiosurgery 1Positron-Emission Tomography 1Photography 1Pemetrexed 1Pafolacianine 1Memantine 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Leucovorin 1Isosorbide 1Irinotecan 1Interleukin-2 1IDRX-42 1High-Intensity Interval Training 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × semaglutide × 30 days × Clear all
NCT07627191 2026-06-05

GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

University of Arizona

Phase EARLY_PHASE1 Not yet recruiting
30 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡